- 全部删除
您的购物车当前为空
KL1333 (NQO1 activator 1) 是口服NAD+调节剂,与 NAD(P)H: 醌氧化还原酶 1 作为底物反应。它改善线粒体脑肌病、乳酸酸中毒和中风样发作成纤维细胞的能量代谢和线粒体功能障碍。它对顺铂诱导的小鼠耳蜗培养耳毒性的保护作用。


为众多的药物研发团队赋能,
让新药发现更简单!
KL1333 (NQO1 activator 1) 是口服NAD+调节剂,与 NAD(P)H: 醌氧化还原酶 1 作为底物反应。它改善线粒体脑肌病、乳酸酸中毒和中风样发作成纤维细胞的能量代谢和线粒体功能障碍。它对顺铂诱导的小鼠耳蜗培养耳毒性的保护作用。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,190 | In stock | |
| 5 mg | ¥ 3,480 | In stock | |
| 10 mg | ¥ 4,960 | In stock | |
| 25 mg | ¥ 7,560 | In stock | |
| 50 mg | ¥ 9,870 | In stock | |
| 100 mg | ¥ 13,700 | In stock | |
| 200 mg | ¥ 18,500 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,970 | In stock |
KL1333 相关产品
| 产品描述 | KL1333 (NQO1 activator 1) enhances energy metabolism and mitochondrial dysfunction in MELAS fibroblasts. Elevated NAD+ levels trigger the activation of SIRT1 and AMPK, and subsequently activates PGC-1α. NQO1 activator 1 is an orally available NAD+ modulator. It reacts with NAD(P)H: NQO1 as a substrate, resulting in increases in intracellular NAD+ levels via NADH oxidation. |
| 别名 | NQO1 activator 1 |
| 分子量 | 240.26 |
| 分子式 | C14H12N2O2 |
| CAS No. | 1800405-30-4 |
| Smiles | CC(C)c1nc-2c([nH]1)C(=O)C(=O)c1ccccc-21 |
| 密度 | 1.329 g/cm3 (Predicted) |
| 颜色 | Red |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 245 mg/mL (1019.73 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容